News
Declines in ESA hyporesponsiveness are significantly associated with increased malignancy risk in patients with CKD not on dialysis.
She was promptly received at the emergency department, urgently stabiliSed and three hours later, wheeled to theatre for surgery. Isabel tearfully said goodbye to her parents as she was handed over to ...
Earlier diagnoses and advancements in treatment options are providing hope for patients with endometrial cancer like Yaca.
An investigational oral targeted therapy, zipalertinib (CLN-081), demonstrated meaningful tumor responses and a manageable ...
"I went from a minor toothache to almost dead in about three days. So any time I hear someone question whether or not to get ...
Rapid advances have revolutionized the treatment of multiple myeloma, providing better disease control and prolonging ...
Learn more about how this delicious green drink can block your body from absorbing iron and what you can do to avoid it ...
ABBV-706 is an ADC targeting SEZ6 developed by AbbVie. It is linked to a topoisomerase 1 inhibitor (TOP1i) via a ...
Possibly quite ignored, nails are an important part of our fingers and toes. Though nails' primary function is to protect the tips of fingers and toes from injury, they also play a role in enhancing ...
In a detail-thin announcement, Amgen said that adding bemarituzumab to chemotherapy improved overall survival, though ...
The approval of GAMMAGARD LIQUID ERC reinforces our commitment to supporting individualized treatment approaches for people with primary immunodeficiency, including a therapeutic option that has the ...
Shares of this biotech giant have lost 16.3% year to date compared with the industry’s decline of 2.7%. The stock has also ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results